Publication | Closed Access
Real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry
70
Citations
23
References
2019
Year
This is the first study to show the real-world effectiveness and safety of ustekinumab administered according to the recommended induction regimen in a cohort of highly refractory CD patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1